These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28561725)

  • 1. Challenges in Opening and Enrolling Patients in Clinical Trials.
    Vose JM; Chuk MK; Giles F
    Am Soc Clin Oncol Educ Book; 2017; 37():139-143. PubMed ID: 28561725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing conflicts of interest in the conduct of clinical trials.
    Morin K; Rakatansky H; Riddick FA; Morse LJ; O'Bannon JM; Goldrich MS; Ray P; Weiss M; Sade RM; Spillman MA
    JAMA; 2002 Jan; 287(1):78-84. PubMed ID: 11754712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint recommendations for a total services account as a factor in simplifying contracts.
    Bruns I; Schade-Brittinger C; Wissing F; Ruppert T; Trillsch M
    Ger Med Sci; 2019; 17():Doc10. PubMed ID: 31728135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating the Murky Waters of Conflict of Interest: Searching for the Middle Path.
    Zonia SC
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):67-71. PubMed ID: 27106892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges With Research Contract Negotiations in Community-Based Cancer Research.
    Thompson MA; Hurley PA; Faller B; Longinette J; Richter K; Stewart TL; Robert N
    J Oncol Pract; 2016 Jun; 12(6):e626-32. PubMed ID: 27143149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
    Yim R
    Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic efficiency of countries' clinical review processes and competitiveness on the market of human experimentation.
    Ippoliti R
    Value Health; 2013; 16(1):148-54. PubMed ID: 23337226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better regulation of industry-sponsored clinical trials is long overdue.
    Wynia M; Boren D
    J Law Med Ethics; 2009; 37(3):410-9, 395. PubMed ID: 19723252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials.
    Tran DT; Akpinar I; Fedorak R; Jonsson E; Mackey J; Richer L; Jacobs P
    J Pharm Pharm Sci; 2017; 20(1):407-414. PubMed ID: 29197429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compact versus contract--industry sponsors' obligations to their research subjects.
    Mello MM; Joffe S
    N Engl J Med; 2007 Jun; 356(26):2737-43. PubMed ID: 17596610
    [No Abstract]   [Full Text] [Related]  

  • 18. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
    Dreier G; Marx C; Schmoor C; Maier-Lenz H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflict of interest.
    Holmes DR; Firth BG; James A; Winslow R; Hodgson PK; Gamble GL; Popp RL; Harrington RA
    Am Heart J; 2004 Feb; 147(2):228-37. PubMed ID: 14760318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials in jeopardy.
    Cleophas GC; Cleophas TJ
    Int J Clin Pharmacol Ther; 2003 Feb; 41(2):51-5. PubMed ID: 12607627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.